Representatives from the two companies emphasized that its effectiveness is still being validated. At this stage, it is to be used for research purposes and not as a diagnostic tool.

A tech giant is offering a free hand to healthcare experts working in various fields that could be tapping tireless AI rather than overworked humans to answer questions from the general public on COVID-19.

The images are rendered from CT scans and allow viewers to navigate the lungs in 360-degree tours, as demonstrated in a video podcast posted by George Washington University Hospital.

Sectra has received FDA clearance for its Digital Pathology Module, a primary diagnostics tool intended for U.S. healthcare providers.

Researchers have used machine learning to develop a blood test that can find 50 or so types of cancer.

A disease that hits most people mildly but some very hard—and so wreaks havoc with its unpredictability among the infected—would seem a good target for AI’s predictive prowess.

Researchers in South Korea have shown that AI trained on photos of both Asian and Caucasian patients can help dermatologists more accurately diagnose many diseases and disorders of the skin in both subpopulations.

A healthcare AI company has spotted several unexpected, off-label drug combinations that may do the job against COVID-19. In any case, the company is offering its complete AI toolkit free of charge to drug developers working on COVID treatments.